KKR sold off its 46.39% stake in J.B. Chemicals and Pharmaceuticals to Torrent Pharma after grooming the Indian drugmaker into a fast-growing business for the past five years.

NEW DELHI: Sun Pharma announced that its India business head, Kirti Ganorkar will be elevated as the company’s managing director to succeed the founder, Dilip Shanghvi, effective September 1.

MARSEILLE, France, June 17, 2025--Innate Pharma announces its participation in H.C. Wainwright and Wolfe Research Healthcare Conferences ...

Independent Sens. | Independent Sens. Bernie Sanders of Vermont and Angus King of Maine have introduced a bill that would ban pharmaceutical companies from advertising directly to consumers. The ...

NAARDEN, The Netherlands and MIAMI, June 09, 2025 (GLOBE NEWSWIRE) -- NewAmsterdam Pharma Company N.V. (Nasdaq: NAMS or “NewAmsterdam” or the “Company”), a late-stage, clinical ...

Thermo Fisher Scientific’s Accelerator™ Drug Development solutions, which integrate services for contract development and manufacturing organizations (CDMOs) and contract research organizations (CROs) ...

JERSEY CITY, N.J., June 20, 2025 /PRNewswire/ -- Mitsubishi Tanabe Pharma America, Inc. (MTPA) today announced poster presentations on investigational ND0612 in Parkinson's disease (PD) will be ...

COLUMBIA, S.C. (WIS) - A pharmaceutical manufacturer is growing their operations in Richland County. Ritedose, a company specializing in Blow-Fill-Seal technology, opened a 225,000-square-foot ...

BridgeBio Pharma, Inc. (NASDAQ:BBIO) is one of the 10 biotech stocks screaming a buy. On June 17, Wolfe Research initiated coverage of the stock with an ‘Outperform’ rating and a $49 price target.

Analyst Price Forecast Suggests 49.69% Upside As of June 2, 2025, the average one-year price target for BridgeBio Pharma is $61.58/share. The forecasts range from a low of $37.37 to a high of $99.75.

Innate Pharma S.A. is a global, clinical-stage biotechnology company developing immunotherapies for cancer patients. Its innovative approach aims to harness the innate immune system through three ...